Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.

MLA

Abu El-Asrar, Ahmed M., et al. “Mycophenolate Mofetil Combined with Systemic Corticosteroids Prevents Progression to Chronic Recurrent Inflammation and Development of ‘Sunset Glow Fundus’ in Initial-Onset Acute Uveitis Associated with Vogt-Koyanagi-Harada Disease.” Acta Ophthalmologica, vol. 95, no. 1, Feb. 2017, pp. 85–90. EBSCOhost, https://doi.org/10.1111/aos.13189.

APA

Abu El-Asrar, A. M., Dosari, M., Hemachandran, S., Gikandi, P. W., & Al-Muammar, A. (2017). Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of “sunset glow fundus” in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease. Acta Ophthalmologica, 95(1), 85–90. https://doi.org/10.1111/aos.13189

Chicago

Abu El-Asrar, Ahmed M, Mona Dosari, Suhail Hemachandran, Priscilla W Gikandi, and Abdulrahman Al-Muammar. 2017. “Mycophenolate Mofetil Combined with Systemic Corticosteroids Prevents Progression to Chronic Recurrent Inflammation and Development of ‘Sunset Glow Fundus’ in Initial-Onset Acute Uveitis Associated with Vogt-Koyanagi-Harada Disease.” Acta Ophthalmologica 95 (1): 85–90. doi:10.1111/aos.13189.